-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Viking Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2017 to Q3 2024.
- Viking Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 111M shares, a 11.1% increase year-over-year.
- Viking Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 94.3M shares, a 22.8% increase from 2022.
- Viking Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 76.8M shares, a 0.47% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)